StockData
Dermata Therapeutics, Inc. logo

Dermata Therapeutics, Inc. (DRMA) stock

DRMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.57−0.03 (-4.75%)

Close on Nov 17, 2026Market cap $2.29MP/E –Yield –

Dermata Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Dermata Therapeutics's market cap was $2.88M on Nov 11, 2026, against $2.65M a year earlier. Over the last 5 years it ranged from $880.34K to $4.50B, with a median of $5.23M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.88M+46.8%
2025Dec 31, 2025$1.96M-13.5%
2024Dec 31, 2024$2.26M-92.2%
2023Dec 29, 2023$29.18M-97.5%
2022Dec 30, 2022$1.19B-65.8%
2021Dec 31, 2021$3.48B–

More Dermata Therapeutics figures

See a number that looks wrong?